CleveX Inc. announced today that it has closed $1.4 million in equity financing. CleveX, Inc. is a growth stage medical device company that is developing and marketing innovative skin excision, biopsy, closure and repair instrumentation. A spin-out of the Cleveland Clinic Foundation, the Company incorporated in December 2006. CleveX technologies significantly enhance practice economics for […]
Less
More
SpectraGenics, Inc., a leader in light-based therapeutic beauty products, today announced the completion of $30 million in new funding. The company also announced a change in their name from SpectraGenics to TRIA Beauty to better reflect their corporate mission and future initiatives. TRIA Beauty, formerly known as SpectraGenics, is a leader in light-based therapeutic beauty […]
Elemé Medical Inc., a private venture-backed aesthetics company building a franchise in the body shaping market with an initial focus on treatment of cellulite, announced today that it has raised $18 million in a Series C financing. The SmoothShapes® System uses a proprietary technology called Photomology® to treat the underlying causes of cellulite. Thermal and […]
Myoscience Inc., a Redwood City, Calif.-based aesthetic medicine startup (Medical devices for dermatology), has raised $8.36 million in Series B funding.
Kythera Biopharmaceuticals, Inc. announced a $40 million C round financing. “This financing is a clear recognition of the progress made on and potential of our lead product candidate, ATX-101, which is currently being evaluated in Phase II clinical trials in Europe, Canada, Australia and the U.S. for minimally-invasive reduction of localized fat,” Kythera has active […]
CynDen Ltd., a UK developer of intense pulsed light-based treatments for cosmetic medical procedures, has raised Gbp2.8 million ($5.458 million) in VC funding. CyDen’s revolutionary iPulse? range of products, which offer light-based treatments for permanent hair reduction, acne, skin blemishes, pigmentation as well as phototherapy for anti-aging and wrinkle reduction, are poised for significant growth […]
Revance Therapeutics, Inc. today announced the completion of an additional $8 million investment to the Series C financing that was completed in December 2007. “We believe the application of botulinum toxin type A without an injection using Revance’s MTS technology, as well as the development of new botulinum toxin molecules, will be of interest globally […]
AGI Dermatics, the biopharmaceutical company focused on the development and sale of skincare products utilizing DNA repair technology, announced today it closed a $5 million investment round. AGI Dermatics is the biopharmaceutical company that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, […]
Miramar Labs Inc., a Menlo Park, Calif., medical-device maker, raised $20.3 million in a second funding round. There isn’t a huge amount of public information about the company, although it appears that the company is working on electromechanical devices of some sort for “aesthetic indications” - cosmetic surgery.
Ulthera, Inc. today announced that it has received $22.5 million in a Series B round. “The company has developed a micro-ablation device that safely penetrates and treats multiple layers of tissue non-invasively,” stated Likens. “Ulthera’s technology is the first to combine high frequency ultrasound imaging and therapeutic treatment in a single device. This unique approach […]
aesthetic medicine
Medical Devices